CONNECT WITH US
Funding Tracker

Funding Tracker

Paytm, Pine Labs, MobiKwik shares tank over 7% amid reports of further UPI MDR delay

Entrackr logo

Published on

Add as a preferred source on Google
Paytm, Pine Labs, MobiKwik shares tank over 7% amid reports of further UPI MDR delay

Shares of digital payments companies Paytm, Pine Labs and Mobikwik came under sharp selling pressure on Thursday after reports suggested that the proposed merchant discount rate (MDR) on select Unified Payments Interface (UPI) transactions could face another delay, potentially extending beyond the 2027 assembly elections.

As of 3:00 PM (today), One 97 Communications, the parent company of Paytm, was trading at Rs 1,741.6, down around 7.85% from its previous close of Rs 1,890. Pine Labs was trading at Rs 161.5, down 4.6%, while MobiKwik was at around Rs 209.9, declining 7.42% from its previous close of Rs 226.72.

The proposed MDR framework was expected to provide an additional revenue stream for payment companies by allowing charges on select high-value merchant UPI transactions. However, according to media reports, the rollout could be pushed beyond the assembly elections scheduled across five states in the first half of 2027, as the government remains cautious about potential opposition from merchants and trade associations.

The rollout was initially scheduled for October 15, 2026, but was deferred until after Diwali following resistance from retailers. The National Payments Corporation of India (NPCI), the Reserve Bank of India (RBI) and the government are yet to arrive at a consensus on a fresh implementation date.

The development comes at a time when Paytm had been witnessing a recovery in its share price, supported by improving financial performance and regulatory developments. The stock had traded at Rs 1,939.70 on November 13, around 9.8% below its IPO price of Rs 2,150.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.